Who to call at GoodRx Holdings, Inc., and when
Fundz watches for the moments GoodRx Holdings, Inc. starts buying, and tells you who to reach.
- An alert the day GoodRx Holdings, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at GoodRx Holdings, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at GoodRx Holdings, Inc.. With Fundz connected, it knows.
GoodRx Holdings, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
www.goodrx.comThe seat is still open. No replacement has been named 359 days after this filing.
See every company with multiple executive changes →AI Executive Summary
AI-powered analysis of 8-K filing content
GoodRx and Co-Chairman Trevor Bezdek mutually agreed to end his employment and executive officer service upon the expiration of his employment agreement on November 1, 2025. He will remain Co-Chairman of the Board as a non-employee director, so the change is a shift from executive to board role rather than a full departure from governance.
Key Takeaways
Bezdek's executive employment and officer role end on November 1, 2025, when his employment agreement expires, but he stays on the Board as Co-Chairman in a non-employee capacity.
As a non-employee director, Bezdek will receive a $30,000 annual Board retainer, a $10,000 Nominating and Corporate Governance Committee retainer, and a $75,000 Co-Chair retainer, all pro-rated for 20
3 more takeaways
Related Filings (6)
6 more filings from GoodRx Holdings, Inc. in the last 90 days
Filing Overview
What This Means
GoodRx Holdings, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.